Clinical Trial Update: Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous dendritic cell therapy and Prevnar vaccine with immune checkpoint inhibition following high-dose external beam radiotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Autologous dendritic cell vaccine (dendritic cell vaccine)
• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Mayo Clinic | Conditions: Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING